Mechanism of Viral Liver Injury by analyzing escape mutant virus and HLA-binding viral peptide
Mechanism of Viral Liver Injury by analyzing escape mutant virus and HLA-binding viral peptide
批准号:
06404029
负责人:
OMATA Masao
金额:
$15.87万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1997
中文摘要
用亲和层析法从稳定表达乙肝病毒的人肝癌细胞株(HepG2 2.2.15)中分离纯化了人类白细胞抗原结合肽。用LC/MS/MS测定人类白细胞抗原结合肽的氨基酸序列为NPLPOLPO,对从慢性乙型肝病患者血清中获得的全长HBVDNA进行测序,根据慢性肝病的进展在核心区和S前区积累氨基酸替换,通过反向聚合酶链式反应、克隆和测序来确定慢性活动性肝炎患者肝脏侵袭性细胞毒性T细胞的T细胞受体α链的谱系。最常见的是Valpha7.2基因与Jalpha33基因结合,我们建立了一步扩增3.2kbpHBVdna的方法。将克隆的全长HBVDNA导入人肝癌细胞(Huh7),证实可复制。我们用Ile、Val、Ala、Leu、Lys、Arg和Thr替换YMDD基序的蛋氨酸,形成了7个突变体,以考察这些突变体的复制能力和拉米夫定的敏感性。4个变异体(Ile、Val、Ala和Leu)保持复制活性,而另外3个变异体(Lys、Arg和Thr)显示复制受损。丙型肝炎病毒(丙型肝炎病毒)、丙型肝炎病毒非结构区5A(NS5A)蛋白在GAL4的DNA结合区未融合146个氨基酸的情况下,在酵母和人肝癌细胞(HuH7)中强烈激活转录。丙型肝炎病毒NS5A蛋白的转录激活可能在病毒复制和肝癌发生中起作用。
英文摘要
Hepatitis B virus (HBV)We purified HLA-binding peptides from HBV stably-transfected human hepatoma cells (HepG2 2.2.15) by affinity chromatography using monoclonal Ab. Amino acid sequence of HLA-binding peptide was determined as NPLPOLPO by HPLC-mass spectrometry (LC/MS/MS).Full-length HBV DNAs obtained from sera of patients with type B-chronic liver diseases were sequenced Amino acid substitutions were accumulated in core-region and pre-S region according to the progression of chronic liver disease.The repertoire of T cell receptor alpha-chain of liver-invaded cytotoxic T cells in patiens with type B-chronic active hepatitis, was determined by inverse PCR,cloning and sequencing. The Valpha 7.2 gene was most frequently observed and found to bind Jalpha 33 gene.We established one-step amplification of 3.2 kbp of full-length HBV DNA by using long-PCR method. Cloned full-length HBV DNA was confirmed to replicate by transfection into human hepatoma cells (Huh7). We made 7 variants by substituting the methionine of the YMDD motif with Ile, Val, Ala, Leu, Lys, Arg and Thr, to explore replication ability and lamivudine sensitivity of these variants. Four variants (Ile, Val, Ala and Leu) remained replication competent, whereas 3 others (Lys, Arg and Thr) showed impaired replication. 2 variants (Ile and Val) were showed to be resistant to lamivudine.Hepatitis C virus (HCV)Hepatitis C virus nonstructural region 5A (NS5A) protein, without its 146 amino-terminal amino acids fused to the DNA-binding domain of GAL4 strongly activates transcription in yeast and human hepatoma cells (Huh7). Transcriptional activation by HCV NS5A protein may play a role in viral replication and hepatocarcinogenesis.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shiratori Y,Shiina S,Zhang PY,Ohno E,Okudaira T,Payawal DA,Ono-Nita SK,Imamura M,Kato N,Omata M.: "Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?" Cancer. 80. 2060-2067 (19
Shiratori Y,Shiina S,Zhang PY,Ohno E,Okudaira T,Payawal DA,Ono-Nita SK,Imamura M,Kato N,Omata M.:“乙型肝炎和丙型肝炎病毒的双重感染在发病机制中发挥重要作用吗?
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kato N: "Hepatitis C virus nonstructural regin 5A plotein is a potent transcriptional activator." J Virol. 71. 8856-8859 (1997)
Kato N:“丙型肝炎病毒非结构性 Regin 5A 蛋白是一种有效的转录激活剂。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yokosuka O: "Efficacy of longterm interseron treatment in chronic liver disease evaluated by sensitive polymerose chain reaction assay for hepatitis C virus RNA" Gut. 37. 721-726 (1995)
Yokosuka O:“通过丙型肝炎病毒 RNA 的敏感聚合糖链反应测定评估长期 Interseron 治疗慢性肝病的疗效”Gut。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shiratori Y: "charcteristic difference of nepatocellular concinoma betueon nepotitis-B and -C nial infection in Japan." Hepatology. 22. 523-527 (1994)
Shiratori Y:“日本的 Nepatocellular concinoma betueon nepotitis-B 型和 C 型 nepotitis-C 型感染的特征差异。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takano S,Satomura Y,Omata M: "Japan Acute Hepatitis Cooperative Study Group. Effects of interferon deta on non-A,non-B acute hepatitis : A prospective, randomized, controlled-dose study." Gastroenterology. 107. 805-811 (1994)
Takano S、Satomura Y、Omata M:“日本急性肝炎合作研究组。干扰素 deta 对非甲型、非乙型急性肝炎的影响:一项前瞻性、随机、对照剂量研究。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 37 条
Inhibition of innate immune system by hepatitis C virus
-
批准号:17209026
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.37万
-
财政年份:2005
-
负责人:OMATA Masao
-
依托单位:
Mechanism of hepatocyte injury via survival and death signaling induced by hepatitis viruses
-
批准号:13307019
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$33.53万
-
财政年份:2001
-
负责人:OMATA Masao
-
依托单位:
The molecular mechanism of te pathogenesis induced by Helicbacter phylori (TN2) and the clinical application
-
批准号:11557040
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.19万
-
财政年份:1999
-
负责人:OMATA Masao
-
依托单位:
Molecular diagrostic assays for hepatic, pancreatic and gastrointestinal cancers
-
批准号:07557044
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$9.02万
-
财政年份:1995
-
负责人:OMATA Masao
-
依托单位:
Integrated studies for inhibition of progression of chronic hepatitis Cleading to hepatocellular
-
批准号:07307009
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$7.42万
-
财政年份:1995
-
负责人:OMATA Masao
-
依托单位:
Investigation of the Mechanism of Fulminant and Severe Hepatitis Correlated with Hepatitis B Virus Mutations
-
批准号:03454223
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.46万
-
财政年份:1991
-
负责人:OMATA Masao
-
依托单位:
Interaction of viral and chemical hepatocarcinogenesis
-
批准号:62480192
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.52万
-
财政年份:1987
-
负责人:OMATA Masao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
LILRB2/HLA-G免疫抑制轴在胶质瘤干细胞免疫逃逸中的作用及其与STAT3信号通路的交互调控机制研究
-
批准号:2026JJ80459
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王彪
-
依托单位:
HLA-DR+中性粒细胞调控儿童噬血细胞综合征细胞因子风暴的机制及临床价值研究
-
批准号:2026JJ81611
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘灿
-
依托单位:
HLA-B*13:01介导阿苯达唑肝损伤的毒理机制及构效关系研究
-
批准号:2026JJ50638
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:饶泰
-
依托单位:
肝内胆管细胞癌中TREM2+巨噬细胞通过增强HLA-C/FAM3C信号通路依赖性淋巴管生成促进肿瘤转移的机制研究
-
批准号:QN25H160111
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:万喆
-
依托单位:
HLA-B27通过肠道菌群失衡致炎促AS发展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郑海雅
-
依托单位:
三阴性乳腺癌HLA-I和HLA-II限制性T细胞表位鉴定与免疫治疗
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邵营宽
-
依托单位:
EBV高危亚型编码的BALF2-HR蛋白上调HLA-II类分子促进鼻咽癌免疫逃逸的机制研究
-
批准号:2025JJ60152
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:葛军尚
-
依托单位:
HLA-C 提高CAR-T 细胞治疗急性淋巴细胞白血病效能及机制的探讨
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张诚
-
依托单位:
HLA-G在胃癌发生发展中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:章霞
-
依托单位:
KIR-HLA受配体相合度对免疫性血小板输注无效的影响及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位: